Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 94 000 KRW -0.63% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?
Write Note

Chong Kun Dang Pharmaceutical Corp
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chong Kun Dang Pharmaceutical Corp
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Cash Interest Paid
â‚©8.6B
CAGR 3-Years
33%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Cash Interest Paid
â‚©12.1B
CAGR 3-Years
62%
CAGR 5-Years
30%
CAGR 10-Years
26%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash Interest Paid
â‚©8.1B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash Interest Paid
â‚©26.9B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash Interest Paid
â‚©1.4B
CAGR 3-Years
61%
CAGR 5-Years
43%
CAGR 10-Years
17%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash Interest Paid
â‚©7.7B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
-2%
No Stocks Found

Chong Kun Dang Pharmaceutical Corp
Glance View

Market Cap
1.2T KRW
Industry
Pharmaceuticals

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Intrinsic Value
98 114.35 KRW
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Chong Kun Dang Pharmaceutical Corp's Cash Interest Paid?
Cash Interest Paid
8.6B KRW

Based on the financial report for Dec 31, 2023, Chong Kun Dang Pharmaceutical Corp's Cash Interest Paid amounts to 8.6B KRW.

What is Chong Kun Dang Pharmaceutical Corp's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
25%

Over the last year, the Cash Interest Paid growth was 34%. The average annual Cash Interest Paid growth rates for Chong Kun Dang Pharmaceutical Corp have been 33% over the past three years , 25% over the past five years .

Back to Top